Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Sickle Cell Anemia Testing & Screening Market, By Technology
7.1. Sickle Cell Anemia Testing & Screening Market, By Technology Type, 2020-2030
7.1.1. Hemoglobin Electrophoresis
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. High-performance Liquid Chromatography (HPLC)
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Point-of-Care Tests
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Other Tests
7.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Sickle Cell Anemia Testing & Screening Market, By Age Group
8.1. Sickle Cell Anemia Testing & Screening Market, By Age Group, 2020-2030
8.1.1. Newborn Screening (12 months and below)
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Adult Screening (25 to 60 years)
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Other Age Groups (1 to 25 & above 60 years)
8.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Sickle Cell Anemia Testing & Screening Market, By Sector Type
9.1. Sickle Cell Anemia Testing & Screening Market, By Sector Type, 2020-2030
9.1.1. Government Labs
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Private Labs
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Corporate Labs
9.1.3.1. Market Revenue and Forecast (2016-2030)
9.1.4. PPP (Public-Private-Partnerships)
9.1.4.1. Market Revenue and Forecast (2016-2030)
Chapter 10. Global Sickle Cell Anemia Testing & Screening Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Technology (2016-2030)
10.1.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.1.3. Market Revenue and Forecast, By Sector Type (2016-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.1.4.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.1.4.3. Market Revenue and Forecast, By Sector Type (2016-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.1.5.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.1.5.3. Market Revenue and Forecast, By Sector Type (2016-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Technology (2016-2030)
10.2.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.2.3. Market Revenue and Forecast, By Sector Type (2016-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.2.4.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.2.4.3. Market Revenue and Forecast, By Sector Type (2016-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.2.5.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.2.5.3. Market Revenue and Forecast, By Sector Type (2016-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Technology (2016-2030)
10.2.6.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.2.6.3. Market Revenue and Forecast, By Sector Type (2016-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Technology (2016-2030)
10.2.7.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.2.7.3. Market Revenue and Forecast, By Sector Type (2016-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Technology (2016-2030)
10.3.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.3.3. Market Revenue and Forecast, By Sector Type (2016-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.3.4.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.3.4.3. Market Revenue and Forecast, By Sector Type (2016-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.3.5.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.3.5.3. Market Revenue and Forecast, By Sector Type (2016-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Technology (2016-2030)
10.3.6.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.3.6.3. Market Revenue and Forecast, By Sector Type (2016-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Technology (2016-2030)
10.3.7.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.3.7.3. Market Revenue and Forecast, By Sector Type (2016-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.4.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.4.3. Market Revenue and Forecast, By Sector Type (2016-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.4.4.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.4.4.3. Market Revenue and Forecast, By Sector Type (2016-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.4.5.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.4.5.3. Market Revenue and Forecast, By Sector Type (2016-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Technology (2016-2030)
10.4.6.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.4.6.3. Market Revenue and Forecast, By Sector Type (2016-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Technology (2016-2030)
10.4.7.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.4.7.3. Market Revenue and Forecast, By Sector Type (2016-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.5.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.5.3. Market Revenue and Forecast, By Sector Type (2016-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Technology (2016-2030)
10.5.4.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.5.4.3. Market Revenue and Forecast, By Sector Type (2016-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Technology (2016-2030)
10.5.5.2. Market Revenue and Forecast, By Age Group (2016-2030)
10.5.5.3. Market Revenue and Forecast, By Sector Type (2016-2030)
Chapter 11. Company Profiles
11.1. STRECK, INC.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Daktari Diagnostics
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. BIOMEDOMICS INC.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Laboratory Corporation of America Holdings
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Request A Test, Ltd.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. HALCYON BIOMEDICAL INCORPORATED
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Silver Lake Research Corporation
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. HEMOTYPE
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. HEMEX HEALTH
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Bio-Rad Laboratories, Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. PerkinElmer Inc.
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Quest Diagnostics
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms